Skip to content

Evaluation of Human Zinc Absorption From Wheat-based Meals

Evaluation of Human Zinc Absorption From Wheat-based Meals

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01775319
Enrollment
54
Registered
2013-01-24
Start date
2013-02-28
Completion date
2014-03-31
Last updated
2016-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Zinc Deficiency

Keywords

Zinc

Brief summary

Study part 1 and 2 Assessment of Zn absorption from regular and biofortified wheat: stable isotope absorption studies in women of childbearing age consuming test meals prepared from either the biofortified Zn wheat, regular wheat or post-harvest fortified wheat at two different extraction rates. Study part 3 Assessment of Zn absorption from intrinsically and extrinsically labeled wheat: stable isotope absorption studies in women of childbearing age, or men, consuming test meals prepared from either intrinsically labeled Zn biofortified wheat, regular wheat or post-harvest fortified wheat extrinsically labeled immediately before consumption.

Detailed description

The overall goal of study part 1 and 2 is to evaluate and compare the fractional and absolute Zn absorption from biofortified wheat cultivar (60 ppm Zn) to regular wheat (28 ppm Zn) and to post harvest fortified wheat (60 ppm Zn) for a total of 3 test meals per study. The studies will be conducted with products based on wheat with high extraction rate (study part 1) and medium extraction rate (study part 2) in two separate groups of women of childbearing age. The goal of study part 3 is to investigate the difference of absorption measurements between intrinsically and extrinsically labeled biofortified wheat. The label of the test meals will have the same nature as the fortificant itself (extrinsic vs intrinsic), for a total of 3 test meals.

Interventions

DIETARY_SUPPLEMENTBiofortified wheat

Extrinsic label 67Zn (ZnSO4) 0.2mg 70Zn added to the IV dose

DIETARY_SUPPLEMENTFortified wheat

Extrinsic label 67Zn (ZnSO4) 0.2mg 70Zn added to the IV dose

DIETARY_SUPPLEMENTPlacebo

Sponsors

HarvestPlus
CollaboratorOTHER
Swiss Federal Institute of Technology
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Female, 18 to 45 years old (Study part 1 and 2). Female or male, 18 to 45 years old (Study part 3) * Body Mass Index in the range of 18.5 to 25 kg/m2 * Signed informed consent

Exclusion criteria

* Any metabolic, gastrointestinal kidney or chronic disease such as diabetes, anemia, hepatitis, hypertension, cancer or cardiovascular diseases (according to the subjects own statement) * Gluten intolerance, celiac disease * Continuous/long-term use of medication during the whole study (except for contraceptives) * Vegans * Consumption of mineral and vitamin supplements within 2 weeks prior to 1st test meal administration * Smoking * Pregnancy (Urine pregnancy test shall be performed before each test meal administration) * Lactating * Earlier participation in a study using Zn stable isotopes or participation in any other clinical study within the last 30 days

Design outcomes

Primary

MeasureTime frameDescription
Fractional zinc absorption from different wheat-based test meals3 monthsFractional zinc absorption (in %) will be assessed with stable isotopes of zinc using a double isotope technique.

Secondary

MeasureTime frame
Zn and C-reactive protein concentration in plasma3 months

Other

MeasureTime frame
Creatinin2 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 3, 2026